Evaluation of the Protein Intake of the Pregnant Woman According to the Weight Status and in Pregnant Women Operated on Bariatric Surgery
BariaProG
2 other identifiers
interventional
120
1 country
1
Brief Summary
Adequate equipment for lifelong health is essential to ensure healthy health for fetal development. In France, pregnant women with normal weight have increased protein intake to 0.78-0.95g / kg / day (ANC 2001). And more recently, AFSSA from 2007 proposed a recommended nutritional intake of 0.82-1g / kg / d. An increased requirements in the second and third trimester of 0.25 g / kg / day and 0.46 g / kg / day, respectively, compared with non-pregnancy values. However, the prevalence of the incompatibility remains unknown. In addition, maternal protein intake is inadequate or excessively associated with both intra-uterine growth retardation and small gestational age weights. Neonatal hypotrophy is also associated with a risk of chronic diseases in adulthood, including cardiovascular disease, type 2 diabetes, insulin resistance, high blood pressure and coronary heart disease. In obese women or patients undergoing surgery for bariatric surgery, there is currently no recommendation on the recommended protein intake. Or, maternal obesity plays a role in the metabolic development of children and bariatric surgery is associated with a major risk of maternal micronutrient deficiencies and intra-uterine growth retardation. Prevalence of obesity in France is currently estimated at 17%. Moreover, bariatric surgery is also fast-growing in France with a number of interventions having tripled since 2006. Thus, a better understanding of maternal food needs and applications throughout pregnancy is needed to improve dietary guidelines and promote fetal, neonatal and long-term health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2018
CompletedFirst Posted
Study publicly available on registry
September 13, 2018
CompletedStudy Start
First participant enrolled
October 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedFebruary 4, 2019
February 1, 2019
9 months
August 30, 2018
February 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Protein intake
In the 3rd trimester = Weight adjusted protein intake (g / kg / day) ± total protein intake (g / d) and protein proportion of total caloric intake (%) using a 3-day diary.
an average of 33 weeks
Secondary Outcomes (3)
link between protein consumption in the 3rd trimester and ultrasound data
an average of 33 weeks
nutritional state (nutritional deficiencies) of pregnant women operated on a bariatric surgery using the biological results at T1, T2, T3.
an average of 7,20 and 33 weeks
protein requirements of the pregnant woman according to the 3 groups
an average of 33 weeks
Study Arms (3)
Group 1
EXPERIMENTALUrinary urea 24 hours and food diary
Group 2
EXPERIMENTALUrinary urea 24 hours and food diary
Group 3
EXPERIMENTALUrinary urea 24 hours and food diary
Interventions
This food diary is to be completed by the patient in the 3rd trimester of pregnancy, on 3 consecutive days and if possible including a weekend day. Finally, the investigator also prescribes a biological analysis: a urinary urea from a 24h diuresis to be collected in the 3rd trimester in a dedicated collector and given that same day.
Eligibility Criteria
You may qualify if:
- \- Pregnant women from 20 amenorrhea weeks.
- Women aged at least 18 years old.
- Women with BMI ≥ 18.5 and \<30 kg / m² = Group 1
- Obese women (BMI ≥ 30 kg / m²) = Group 2
- Women operated on a bariatric surgery (by-pass, sleeve-gastrectomy, gastric band) = Group 3
You may not qualify if:
- \- Women with BMI \<18.5 kg / m²
- Troubles of eating behavior
- Women with gestational diabetes
- Medical history of type 1 or type 2 diabetes
- Multiple pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Clermont-Ferrand
Clermont-Ferrand, 63003, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yves BOIRIE
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2018
First Posted
September 13, 2018
Study Start
October 10, 2018
Primary Completion
June 30, 2019
Study Completion
March 30, 2020
Last Updated
February 4, 2019
Record last verified: 2019-02